Suppression of the proliferation of human U-87 MG glioblastoma cells by new antagonists of growth hormone-releasing hormone in vivo and in vitro. (Q39201247)

From Wikidata

Jump to navigation Jump to search

scientific article published on February 2013

Language	Label	Description	Also known as
English	Suppression of the proliferation of human U-87 MG glioblastoma cells by new antagonists of growth hormone-releasing hormone in vivo and in vitro.	scientific article published on February 2013

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23371031 AND SRC:MED&resulttype=core&format=json

23 February 2020

Suppression of the proliferation of human U-87 MG glioblastoma cells by new antagonists of growth hormone-releasing hormone in vivo and in vitro (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23371031 AND SRC:MED&resulttype=core&format=json

23 February 2020

1 reference

based on heuristic

inferred from title

Miklos Jaszberenyi

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23371031 AND SRC:MED&resulttype=core&format=json

23 February 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23371031 AND SRC:MED&resulttype=core&format=json

23 February 2020

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23371031 AND SRC:MED&resulttype=core&format=json

23 February 2020

3

object named as

Norman L Block

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23371031 AND SRC:MED&resulttype=core&format=json

23 February 2020

Irving Vidaurre

6

object named as

Irving Vidaurre

1 reference

Europe PubMed Central

PubMed publication ID

23 February 2020

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23371031 AND SRC:MED&resulttype=core&format=json

7

object named as

Luca Szalontay

1 reference

Europe PubMed Central

PubMed publication ID

23 February 2020

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23371031 AND SRC:MED&resulttype=core&format=json

author name string

Marta Zarandi

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23371031 AND SRC:MED&resulttype=core&format=json

23 February 2020

Ren-Zhi Cai

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23371031 AND SRC:MED&resulttype=core&format=json

23 February 2020

Arumugam R Jayakumar

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23371031 AND SRC:MED&resulttype=core&format=json

23 February 2020

publication date

1 February 2013

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23371031 AND SRC:MED&resulttype=core&format=json

23 February 2020

Targeted oncology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23371031 AND SRC:MED&resulttype=core&format=json

23 February 2020

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23371031 AND SRC:MED&resulttype=core&format=json

23 February 2020

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23371031 AND SRC:MED&resulttype=core&format=json

23 February 2020

281-290

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23371031 AND SRC:MED&resulttype=core&format=json

23 February 2020

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

1 reference

https://api.crossref.org/works/10.1007/S11523-013-0264-Y

21 January 2018

Growth hormone-releasing hormone: extrapituitary effects in physiology and pathology

1 reference

https://api.crossref.org/works/10.1007/S11523-013-0264-Y

21 January 2018

Drug Insight: clinical use of agonists and antagonists of luteinizing-hormone-releasing hormone.

1 reference

https://api.crossref.org/works/10.1007/S11523-013-0264-Y

21 January 2018

Antagonists of growth-hormone-releasing hormone: an emerging new therapy for cancer

1 reference

https://api.crossref.org/works/10.1007/S11523-013-0264-Y

21 January 2018

New approaches to treatment of various cancers based on cytotoxic analogs of LHRH, somatostatin and bombesin

1 reference

https://api.crossref.org/works/10.1007/S11523-013-0264-Y

21 January 2018

Hypothalamic hormones and cancer

1 reference

https://api.crossref.org/works/10.1007/S11523-013-0264-Y

21 January 2018

Combination of gastrin-releasing peptide antagonist with cytotoxic agents produces synergistic inhibition of growth of human experimental colon cancers

1 reference

https://api.crossref.org/works/10.1007/S11523-013-0264-Y

21 January 2018

Targeted cytotoxic somatostatin analog AN-162 inhibits growth of human colon carcinomas and increases sensitivity of doxorubicin resistant murine leukemia cells.

1 reference

https://api.crossref.org/works/10.1007/S11523-013-0264-Y

21 January 2018

Inhibition of human non-small cell lung cancers with a targeted cytotoxic somatostatin analog, AN-162.

1 reference

https://api.crossref.org/works/10.1007/S11523-013-0264-Y

21 January 2018

Antagonists of growth hormone-releasing hormone (GHRH) reduce prostate size in experimental benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1007/S11523-013-0264-Y

21 January 2018

Combining growth hormone-releasing hormone antagonist with luteinizing hormone-releasing hormone antagonist greatly augments benign prostatic hyperplasia shrinkage

1 reference

https://api.crossref.org/works/10.1007/S11523-013-0264-Y

21 January 2018

The effect of GHRH antagonists on human glioblastomas and their mechanism of action

1 reference

https://api.crossref.org/works/10.1007/S11523-013-0264-Y

21 January 2018

The expression of growth hormone-releasing hormone (GHRH) and its receptor splice variants in human breast cancer lines; the evaluation of signaling mechanisms in the stimulation of cell proliferation

1 reference

https://api.crossref.org/works/10.1007/S11523-013-0264-Y

21 January 2018

Novel antagonists of growth hormone-releasing hormone inhibit growth and vascularization of human experimental ovarian cancers

1 reference

https://api.crossref.org/works/10.1007/S11523-013-0264-Y

21 January 2018

Antagonists of growth hormone-releasing hormone inhibit growth of androgen-independent prostate cancer through inactivation of ERK and Akt kinases

1 reference

https://api.crossref.org/works/10.1007/S11523-013-0264-Y

21 January 2018

Antagonists of growth hormone-releasing hormone suppress in vivo tumor growth and gene expression in triple negative breast cancers

1 reference

https://api.crossref.org/works/10.1007/S11523-013-0264-Y

21 January 2018

Growth hormone-releasing hormone antagonists inhibit growth of human ovarian cancer.

1 reference

https://api.crossref.org/works/10.1007/S11523-013-0264-Y

21 January 2018

Beneficial effects of novel antagonists of GHRH in different models of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1007/S11523-013-0264-Y

21 January 2018

Clinical, cellular, and molecular aspects of cancer invasion

1 reference

https://api.crossref.org/works/10.1007/S11523-013-0264-Y

21 January 2018

Cell death in the nervous system

1 reference

https://api.crossref.org/works/10.1007/S11523-013-0264-Y

21 January 2018

Autophagy as a mediator of chemotherapy-induced cell death in cancer

1 reference

https://api.crossref.org/works/10.1007/S11523-013-0264-Y

21 January 2018

Normalization of the Vasculature for Treatment of Cancer and Other Diseases

1 reference

https://api.crossref.org/works/10.1007/S11523-013-0264-Y

21 January 2018

Growth hormone-releasing hormone: an autocrine growth factor for small cell lung carcinoma.

1 reference

https://api.crossref.org/works/10.1007/S11523-013-0264-Y

21 January 2018

Antagonists of growth hormone-releasing hormone inhibit the growth of U-87MG human glioblastoma in nude mice.

1 reference

https://api.crossref.org/works/10.1007/S11523-013-0264-Y

21 January 2018

A correlation of endocrine and anticancer effects of some antagonists of GHRH.

1 reference

https://api.crossref.org/works/10.1007/S11523-013-0264-Y

21 January 2018

Antagonists of growth hormone-releasing hormone cross the blood-brain barrier: a potential applicability to treatment of brain tumors

1 reference

https://api.crossref.org/works/10.1007/S11523-013-0264-Y

21 January 2018

Establishing intracranial brain tumor xenografts with subsequent analysis of tumor growth and response to therapy using bioluminescence imaging

1 reference

https://api.crossref.org/works/10.1007/S11523-013-0264-Y

21 January 2018

Molecular profiling indicates orthotopic xenograft of glioma cell lines simulate a subclass of human glioblastoma

1 reference

https://api.crossref.org/works/10.1007/S11523-013-0264-Y

21 January 2018

Stereotactic intracranial implantation and in vivo bioluminescent imaging of tumor xenografts in a mouse model system of glioblastoma multiforme.

1 reference

https://api.crossref.org/works/10.1007/S11523-013-0264-Y

21 January 2018

Agonist of growth hormone-releasing hormone as a potential effector for survival and proliferation of pancreatic islets

1 reference

https://api.crossref.org/works/10.1007/S11523-013-0264-Y

21 January 2018

The role of autophagy in cancer development and response to therapy.

1 reference

https://api.crossref.org/works/10.1007/S11523-013-0264-Y

21 January 2018

Autophagy, the Trojan horse to combat glioblastomas

1 reference

https://api.crossref.org/works/10.1007/S11523-013-0264-Y

21 January 2018

GHRH antagonist MZ-5-156 increases the expression of AMPK in A549 lung cancer cells

1 reference

https://api.crossref.org/works/10.1007/S11523-013-0264-Y

21 January 2018

Death and anti-death: tumour resistance to apoptosis

1 reference

https://api.crossref.org/works/10.1007/S11523-013-0264-Y

21 January 2018

Synthetic Smac peptide enhances the effect of etoposide-induced apoptosis in human glioblastoma cell lines

1 reference

https://api.crossref.org/works/10.1007/S11523-013-0264-Y

21 January 2018

RAS/RAF pathway activation in gliomas: the result of copy number gains rather than activating mutations

1 reference

https://api.crossref.org/works/10.1007/S11523-013-0264-Y

21 January 2018

TGF-beta, neuronal stem cells and glioblastoma

1 reference

https://api.crossref.org/works/10.1007/S11523-013-0264-Y

21 January 2018

NF-kB and c-Jun induce the expression of the oncogenic miR-221 and miR-222 in prostate carcinoma and glioblastoma cells

1 reference

https://api.crossref.org/works/10.1007/S11523-013-0264-Y

21 January 2018

Nuclear factor-kappaB in cancer development and progression

1 reference

https://api.crossref.org/works/10.1007/S11523-013-0264-Y

21 January 2018

IAPs: from caspase inhibitors to modulators of NF-kappaB, inflammation and cancer

1 reference

https://api.crossref.org/works/10.1007/S11523-013-0264-Y

21 January 2018

Mtss1 regulates epidermal growth factor signaling in head and neck squamous carcinoma cells

1 reference

https://api.crossref.org/works/10.1007/S11523-013-0264-Y

21 January 2018

Targeting integrin-linked kinase inhibits Akt signaling pathways and decreases tumor progression of human glioblastoma

1 reference

https://api.crossref.org/works/10.1007/S11523-013-0264-Y

21 January 2018

In situ analysis of integrin and growth factor receptor signaling pathways in human glioblastomas suggests overlapping relationships with focal adhesion kinase activation

1 reference

https://api.crossref.org/works/10.1007/S11523-013-0264-Y

21 January 2018

Inhibition of growth of experimental human endometrial cancer by an antagonist of growth hormone-releasing hormone

1 reference

https://api.crossref.org/works/10.1007/S11523-013-0264-Y

21 January 2018

Dose-dependent growth inhibition in vivo of PC-3 prostate cancer with a reduction in tumoral growth factors after therapy with GHRH antagonist MZ-J-7-138.

1 reference

https://api.crossref.org/works/10.1007/S11523-013-0264-Y

21 January 2018

Cell type-specific expression of angiopoietin-1 and angiopoietin-2 suggests a role in glioblastoma angiogenesis

1 reference

https://api.crossref.org/works/10.1007/S11523-013-0264-Y

21 January 2018

Antiangiogenic therapies for high-grade glioma

1 reference

https://api.crossref.org/works/10.1007/S11523-013-0264-Y

21 January 2018

Epidermal growth factor and pro-inflammatory cytokines regulate the expression of components of plasminogen activation system in U373-MG astrocytoma cells.

1 reference

https://api.crossref.org/works/10.1007/S11523-013-0264-Y

21 January 2018

LGI1, a putative tumor metastasis suppressor gene, controls in vitro invasiveness and expression of matrix metalloproteinases in glioma cells through the ERK1/2 pathway

1 reference

https://api.crossref.org/works/10.1007/S11523-013-0264-Y

21 January 2018

GHRH antagonists reduce the invasive and metastatic potential of human cancer cell lines in vitro

1 reference

https://api.crossref.org/works/10.1007/S11523-013-0264-Y

21 January 2018

Role of gamma-synuclein in microtubule regulation

1 reference

https://api.crossref.org/works/10.1007/S11523-013-0264-Y

21 January 2018

S100A4 and metastasis: a small actor playing many roles

1 reference

https://api.crossref.org/works/10.1007/S11523-013-0264-Y

21 January 2018

Transforming growth factor-beta: a molecular target for the future therapy of glioblastoma

1 reference

https://api.crossref.org/works/10.1007/S11523-013-0264-Y

21 January 2018

Synergistic inhibition of growth of lung carcinomas by antagonists of growth hormone-releasing hormone in combination with docetaxel

1 reference

https://api.crossref.org/works/10.1007/S11523-013-0264-Y

21 January 2018

GHRH antagonist when combined with cytotoxic agents induces S-phase arrest and additive growth inhibition of human colon cancer

1 reference

https://api.crossref.org/works/10.1007/S11523-013-0264-Y

21 January 2018

Potentiation of mammary cancer inhibition by combination of antagonists of growth hormone-releasing hormone with docetaxel.

1 reference

https://api.crossref.org/works/10.1007/S11523-013-0264-Y

21 January 2018

Increased activity of antagonists of growth hormone-releasing hormone substituted at positions 8, 9, and 10.

1 reference

https://api.crossref.org/works/10.1007/S11523-013-0264-Y

21 January 2018

The inhibitory effect of a novel cytotoxic somatostatin analogue AN-162 on experimental glioblastoma

1 reference

https://api.crossref.org/works/10.1007/S11523-013-0264-Y

21 January 2018

The effect of a novel antagonist of growth hormone releasing hormone on cell proliferation and on the key cell signaling pathways in nine different breast cancer cell lines.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23371031

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of benzodiazepines and neurosteroids on ammonia-induced swelling in cultured astrocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/23371031

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Towards understanding the mode of action of the multifaceted cell adhesion receptor CD146

1 reference

https://pubmed.ncbi.nlm.nih.gov/23371031

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A method using 3-O-methyl-D-glucose and phloretin for the determination of intracellular water space of cells in monolayer culture

1 reference

https://pubmed.ncbi.nlm.nih.gov/23371031

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Integrin involvement in glioblastoma multiforme: possible regulation by NF-kappaB.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23371031

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Powerful inhibition of in-vivo growth of experimental hepatic cancers by bombesin/gastrin-releasing peptide antagonist RC-3940-II.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23371031

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11523-013-0264-Y

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23371031 AND SRC:MED&resulttype=core&format=json

23 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23371031 AND SRC:MED&resulttype=core&format=json

23 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39201247&oldid=2202674819"